Trafficking and functional defects by mutations of the ATP-binding domains in MRP2 in patients with Dubin-Johnson syndrome

Dubin, 1954, Chronic idiopathic jaundice with unidentified pigment in liver cells: new clinico-pathologic entity with report of 12 cases, Medicine, 33, 155, 10.1097/00005792-195409000-00001 Sprinz, 1954, Persistent nonhemolytic hyperbilirubinemia associated with lipochrome-like pigment in liver cells: report of 4 cases, Ann Int Med, 41, 952, 10.7326/0003-4819-41-5-952 Shani, 1970, Dubin-Johnson syndrome in Israel. I. Clinical, laboratory, and genetic aspects of 101 cases, Q J Med, 39, 549 Kondo, 1974, Clinical and genetic studies on Dubin-Johnson syndrome in a cluster area in Japan, Jpn J Hum Genet, 18, 378 Keppler, 1996, The canalicular conjugate export pump encoded by the cmrp/cmoat gene, Prog Liver Dis, 14, 55 Buchler, 1996, cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats, J Biol Chem, 271, 15091, 10.1074/jbc.271.25.15091 Paulusma, 1996, Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene, Science, 271, 1126, 10.1126/science.271.5252.1126 Ito, 1997, Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR, Am J Physiol, 272, G16 Taniguchi, 1996, A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation, Cancer Res, 56, 4124 Kool, 1997, Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines, Cancer Res, 57, 3537 Paulusma, 1997, A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome, Hepatology, 25, 1539, 10.1002/hep.510250635 Wada, 1998, Mutations in the canilicular multispecific organic anion transporter (cMOAT) gene, a novel ABC transporter, in patients with hyperbilirubinemia II/Dubin-Johnson syndrome, Hum Mol Genet, 7, 203, 10.1093/hmg/7.2.203 Toh, 1999, Genomic structure of the canalicular multispecific organic anion-transporter gene (MRP2/cMOAT) and mutations in the ATP-binding cassette region in Dubin-Johnson syndrome, Am J Hum Genet, 64, 739, 10.1086/302292 Hopfner, 2000, Structural biology of Rad50 ATPase: ATP-driven conformational control in DNA double-strand break repair and the ABC-ATPase superfamily, Cell, 101, 789, 10.1016/S0092-8674(00)80890-9 Tsujii, 1999, Exon-intron organization of the human multidrug-resistance protein 2 (MRP2) gene mutated in Dubin-Johnson syndrome, Gastroenterology, 117, 653, 10.1016/S0016-5085(99)70459-2 Keitel, 2000, Impaired protein maturation of the conjugate export pump multidrug resistance protein 2 as a consequence of a deletion mutation in Dubin-Johnson syndrome, Hepatology, 32, 1317, 10.1053/jhep.2000.19791 Kajihara, 1998, A splice mutation in the human canalicular multispecific organic anion transporter gene causes Dubin-Johnson syndrome, Biochem Biophys Res Commun, 253, 454, 10.1006/bbrc.1998.9780 Mor-Cohen, 2001, Identification and functional analysis of two novel mutations in the multidrug resistance protein 2 gene in Israeli patients with Dubin-Johnson syndrome, J Biol Chem, 276, 36923, 10.1074/jbc.M105047200 Evers, 1998, Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA, J Clin Invest, 101, 1310, 10.1172/JCI119886 Kawabe, 1999, Enhanced transport of anticancer agents and leukotriene C4 by the human canalicular multispecific organic anion transporter (cMOAT/MRP2), FEBS Lett, 456, 327, 10.1016/S0014-5793(99)00979-5 Uchiumi, 1997, Cell cycle regulation of the human polo-like kinase (PLK) promoter, J Biol Chem, 272, 9166, 10.1074/jbc.272.14.9166 Chen, 1999, Effect of multidrug resistance-reversing agents on transporting activity of human canalicular multispecific organic anion transporter, Mol Pharmacol, 56, 1219, 10.1124/mol.56.6.1219 Hinoshita, 2000, Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas, Clin Cancer Res, 6, 2401 Yoshimura, 1987, Low binding capacity and altered O-linked glycosylation of low density lipoprotein receptor in a monensin-resistant mutant of Chinese hamster ovary cells, J Biol Chem, 262, 13299, 10.1016/S0021-9258(18)45201-5 Shite, 1990, Differential effects of brefeldin A on sialylation of N- and O-linked oligosaccharides in low density lipoprotein receptor and epidermal growth factor receptor, J Biol Chem, 265, 17385, 10.1016/S0021-9258(18)38168-7 Seguchi, 1992, Brefeldin A-resistant mutants of human epidermoid carcinoma cell line with structural changes of the Golgi apparatus, J Biol Chem, 267, 11626, 10.1016/S0021-9258(19)49957-2 Koike, 1997, A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells, Cancer Res, 57, 5475 Koike, 1996, Overexpression of multidrug resistance protein gene in human cancer cell lines selected for drug resistance to epipodophyllotoxins, Jpn J Cancer Res, 87, 765, 10.1111/j.1349-7006.1996.tb00290.x Terlouw, 2001, Role of multidrug resistance protein 2 (MRP2) in glutathione-bimane efflux from Caco-2 and rat renal proximal tubule cells, Br J Pharmacol, 134, 931, 10.1038/sj.bjp.0704284 Cornwell, 1986, Increased vinblastine binding to membrane vesicles from multidrug-resistant KB cells, J Biol Chem, 261, 7921, 10.1016/S0021-9258(19)57491-9 Taguchi, 1997, Anti-cancer drugs and glutathione stimulate vanadate-induced trapping of nucleotide in multidrug resistance-associated protein (MRP), FEBS Lett, 401, 11, 10.1016/S0014-5793(96)01421-4 Roelofsen, 1998, Cyclic AMP stimulates sorting of the canalicular organic anion transporter (Mrp2/cMoat) to the apical domain in hepatocyte couplets, J Cell Sci, 111, 1137, 10.1242/jcs.111.8.1137 Gao, 2000, Comparison of the functional characteristics of the nucleotide binding domains of multidrug resistance protein 1, J Biol Chem, 275, 13098, 10.1074/jbc.275.17.13098 Nagata, 2000, Nonequivalent nucleotide trapping in the two nucleotide binding folds of the human multidrug resistance protein MRP1, J Biol Chem, 275, 17626, 10.1074/jbc.M000792200 van Aubel, 1998, Adenosine triphosphate-dependent transport of anionic conjugates by the rabbit multidrug resistance-associated protein Mrp2 expressed in insect cells, Mol Pharmacol, 53, 1062 Schwartz, 1999, The ubiquitin-proteasome pathway and pathogenesis of human diseases, Annu Rev Med, 50, 57, 10.1146/annurev.med.50.1.57 Jensen, 1995, Multiple proteolytic systems, including the proteasome, contribute to CFTR processing, Cell, 83, 129, 10.1016/0092-8674(95)90241-4 Hung, 1998, Crystal structure of the ATP-binding subunit of an ABC transporter, Nature, 396, 703, 10.1038/25393 Dork, 1994, Detection of more than 50 different CFTR mutations in a large group of German cystic fibrosis patients, Hum Genet, 94, 533, 10.1007/BF00211022 Diederichs, 2000, Crystal structure of MalK, the ATPase subunit of the trehalose/maltose ABC transporter of the archaeon Thermococcus litoralis, EMBO J, 19, 5951, 10.1093/emboj/19.22.5951